Temporary Circulatory Support and Extracorporeal Membrane Oxygenation - 07/10/18

Doi : 10.1016/j.ccl.2018.06.002

Kimber Eleuteri, MSN, ACNP ^a,^⁎ , Michael Mathias Koerner, MD, PhD ^b, Douglas Horstmanshof, MD ^c, Aly El Banayosy, MD ^c
^a Mechanical Circulatory Support, Medtronic, 500 Old Connecticut Path, Framingham, MA 01701, USA
^b Cardiovascular Intensive Care, Integris Baptist Medical Center, 3300 Northwest Expressway, Oklahoma City, OK 73112, USA
^c Department of Heart Failure Cardiology, Integris Baptist Medical Center, 3300 Northwest Expressway, Oklahoma City, OK 73112, USA

^∗Corresponding author. 245 Simpson Road, Marlborough, MA 01752.245 Simpson RoadMarlboroughMA01752

Résumé

Cardiogenic shock (CS) refractory to conventional therapies continues to be a challenging medical syndrome, with poor prognosis and high complication and mortality rates. The application and use of temporary mechanical circulatory support (MCS) is a component in the treatment of CS patients and should be applied early in the presentation. Crucial to the success of their application, temporary MCS devices should be chosen based on degree of patient acuity and etiology of CS. Not all temporary MCS devices deliver the same degree of hemodynamic support and range from minimal support to systemic support via veno-arterial extracorporeal membrane oxygenation.

Le texte complet de cet article est disponible en PDF.

Keywords : Cardiogenic shock, Temporary mechanical circulatory support, ECMO, V-A ECMO, Decompensated heart failure, Acute on chronic heart failure